AGTRAP (Q6RW13) variants and mutations

AGTRAP (also known as Q6RW13) is a human protein-coding gene encoding a type-1 angiotensin II receptor-associated protein. It helps limit angiotensin II signaling by promoting internalization of the type 1 angiotensin receptor. This regulation influences receptor responsiveness and angiotensin-driven cell growth, linking it to the control of vascular and metabolic signaling. This analysis covers 277 AGTRAP variants and mutations. Of these, 98% have computational variant effect predictions. Disease context includes cancer, hepatocellular carcinoma, and hydrops fetalis. Example AGTRAP variants include E2*, E2V, and E2G.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable AGTRAP variants

Examples include E2*, E2V, E2G, E2E, E2D, L3P, L3M, L3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.